Matches in SemOpenAlex for { <https://semopenalex.org/work/W2488851041> ?p ?o ?g. }
Showing items 1 to 41 of
41
with 100 items per page.
- W2488851041 endingPage "311" @default.
- W2488851041 startingPage "285" @default.
- W2488851041 abstract "The treatment of infants with established bronchopulmonary dysplasia (BPD) remains a common, frustrating, and expensive problem in neonatology, pediatric pulmonology, pediatric critical care, and general pediatrics. Although some believe that BPD prevalence is falling, partly owing to maternal corticosteroid use, and that BPD infants have less severe disease than in the past, these opinions have not yet been documented. BPD follow-up programs remain active in most pediatric centers, and are as busy as ever. Much progress has been made recently in understanding the antecedents of BPD, and risk factors for its development are well known (1,2). In the past decade, the use of surfactant replacement, highfrequency ventilation, and perhaps some modes of corticosteroid therapy have improved the survival rates of very low birth weight (VLBW) infants, but have not reduced the prevalence of BPD. In addition, several biologically plausible therapies have been developed. These include prenatal treatment with glucocorticoid and thyrotropin-releasing hormone (TRH), which showed substantial promise (3), and early treatment of infants at risk with corticosteroids (4,5), inositol (6), superoxide dismutase (7), and α1-protease inhibitor (8,9). Unfortunately, recent clinical trials have shown that neither prenatal TRH-glucocorticoid therapy (10)258 Hazinskinor postnatal α1-protease inhibitor (11) significantly reduced the incidence or severity of BPD. It is possible that newer forms of mechanical ventilation, including perfluorocarbon-assisted (12) and patient-triggered (13,14), may reduce the incidence or severity of BPD. However, there is still no scientifically proved and widely accepted method to prevent BPD." @default.
- W2488851041 created "2016-08-23" @default.
- W2488851041 creator A5081693305 @default.
- W2488851041 date "1999-09-21" @default.
- W2488851041 modified "2023-09-27" @default.
- W2488851041 title "Drug Treatment for Established BPD" @default.
- W2488851041 cites W2257189870 @default.
- W2488851041 doi "https://doi.org/10.1201/b14831-16" @default.
- W2488851041 hasPublicationYear "1999" @default.
- W2488851041 type Work @default.
- W2488851041 sameAs 2488851041 @default.
- W2488851041 citedByCount "2" @default.
- W2488851041 countsByYear W24888510412015 @default.
- W2488851041 crossrefType "book-chapter" @default.
- W2488851041 hasAuthorship W2488851041A5081693305 @default.
- W2488851041 hasConcept C177713679 @default.
- W2488851041 hasConcept C2780035454 @default.
- W2488851041 hasConcept C71924100 @default.
- W2488851041 hasConcept C98274493 @default.
- W2488851041 hasConceptScore W2488851041C177713679 @default.
- W2488851041 hasConceptScore W2488851041C2780035454 @default.
- W2488851041 hasConceptScore W2488851041C71924100 @default.
- W2488851041 hasConceptScore W2488851041C98274493 @default.
- W2488851041 hasLocation W24888510411 @default.
- W2488851041 hasOpenAccess W2488851041 @default.
- W2488851041 hasPrimaryLocation W24888510411 @default.
- W2488851041 hasRelatedWork W139915386 @default.
- W2488851041 hasRelatedWork W1492203295 @default.
- W2488851041 hasRelatedWork W1725690454 @default.
- W2488851041 hasRelatedWork W19310164 @default.
- W2488851041 hasRelatedWork W1974943129 @default.
- W2488851041 hasRelatedWork W2053898680 @default.
- W2488851041 hasRelatedWork W2396557777 @default.
- W2488851041 hasRelatedWork W2589046986 @default.
- W2488851041 hasRelatedWork W3129813277 @default.
- W2488851041 isParatext "false" @default.
- W2488851041 isRetracted "false" @default.
- W2488851041 magId "2488851041" @default.
- W2488851041 workType "book-chapter" @default.